Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years-Reference-Cited by-同舟云学术

Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

Published:2022-07-19 Issue:3 Volume:19 Page:1020-1028
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Beyer Léon¹²,Stocker Hannah³⁴,Rujescu Dan⁵,Holleczek Bernd⁶,Stockmann Julia¹²,Nabers Andreas¹²,Brenner Hermann³⁴,Gerwert Klaus¹²

Affiliation:

1. Center for Protein Diagnostics (PRODI) Ruhr‐University Bochum Bochum Germany

2. Department of Biophysics Ruhr‐University Bochum Bochum Germany

3. Network Aging Research Heidelberg University Heidelberg Germany

4. Division of Clinical Epidemiology and Aging Research German Cancer Research Center Heidelberg Germany

5. Department of Psychiatry Medical University of Vienna Vienna Austria

6. Saarland Cancer Registry Saarbrücken Germany

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12745

Reference49 articles.

1. GreenblattC World Health Organization.Dementia. [September 28 2021]; Available from:https://www.who.int/news‐room/fact‐sheets/detail/dementia

2. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

3. Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer’s disease

4. An Update on Blood-Based Markers of Alzheimer’s Disease Using the SiMoA Platform

5. Neurofilament light chain — new potential for prediction and prognosis

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effects of GFAP and Aβ42: Implications for white matter integrity and verbal memory across the cognitive spectrum;Brain, Behavior, & Immunity - Health;2024-10

2. Alpha-synuclein misfolding as a fluid biomarker for Parkinson’s disease and synucleinopathies measured with the iRS platform;2024-09-04

3. An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein;Advanced Healthcare Materials;2024-09-02

4. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer’s disease;Molecular Neurodegeneration;2024-07-30

5. Tracking neuroinflammatory biomarkers in Alzheimer’s disease: a strategy for individualized therapeutic approaches?;Journal of Neuroinflammation;2024-07-30